Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioma × Electric Stimulation × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Vomiting 1 Shoulder Pain 1 Postoperative Nausea and Vomiting 1 Muscular Atrophy 1 Lymphedema 1 Glioma 1 Gastrointestinal Neoplasms 1 Edema 1 Colorectal Neoplasms 1

Interventions

Temozolomide 140 Bevacizumab 63 Radiotherapy 54 Magnetic Resonance Spectroscopy 52 Irinotecan 27 Carboplatin 23 Surgical Procedures, Operative 18 Radiation 18 Carmustine 18 Specimen Handling 17 Nivolumab 16 Lomustine 15 Biopsy 15 Aminolevulinic Acid 15 pembrolizumab 12 Radiotherapy, Intensity-Modulated 12 Cyclophosphamide 12 trametinib 11 Topotecan 11 Radiosurgery 11 Erlotinib Hydrochloride 11 fluorodopa F 18 9 IL13-PE38 9 Everolimus 9 ribociclib 8 dabrafenib 8 X-Rays 8 Imatinib Mesylate 8 Filgrastim 8 Etoposide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07465796 2026-03-12

CIPHER

Coherence Neuro Australia Pty Limited

Phase NA Not yet recruiting

Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡